Marcel Botha, cofounder and CEO of 10XBeta, warns that President Trump's tariffs may jeopardize the quality and safety of medical innovations and hinder patient care.
The funds will be used to help the company expand into the employer and health plan markets and speed up the development of its AI technology for providers and members.
The company began trading on the NYSE today under the ticker symbol HNGE, opening at $39.25, up 23% from its IPO price of $32, and closing at $37.56 per share.
MobiHealthNews examines the impact of automated dispensing cabinets, robotic surgery, AI in radiology and smart screens on patients' receiving and physicians' delivering care.
MedGemma, built on Gemma 3, aims to help developers build AI-based healthcare applications with open models, including multimodal and text-only versions.